NasdaqCM - Nasdaq Real Time Price USD
Celularity Inc. (CELU)
1.6850
+0.0750
+(4.66%)
As of 12:54:44 PM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-12,336
-38,685
-137,876
-110,096
-63,193
Investing Cash Flow
1,490
-4,048
-5,236
-5,903
-12,815
Financing Cash Flow
6,044
24,094
119,838
98,562
102,014
End Cash Position
10,296
10,163
28,802
52,076
69,513
Income Tax Paid Supplemental Data
-11
--
--
--
13
Interest Paid Supplemental Data
144
1,073
--
146
--
Capital Expenditure
-685
-4,048
-5,236
-6,203
-27,834
Issuance of Capital Stock
6,000
21,886
36,519
83,400
102,535
Issuance of Debt
21,362
20,369
85,691
5,000
--
Repayment of Debt
-17,480
-16,811
--
-5,000
--
Repurchase of Capital Stock
--
--
--
--
-256
Free Cash Flow
-13,021
-42,733
-143,112
-116,299
-91,027
12/31/2020 - 8/8/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AARD Aardvark Therapeutics, Inc. Common Stock
8.30
-2.58%
SRNE Sorrento Therapeutics, Inc.
0.0009
0.00%
TENX Tenax Therapeutics, Inc.
5.56
+1.74%
COEP Coeptis Therapeutics Holdings, Inc.
12.08
+5.78%
TCBPY TC Biopharm (Holdings) Plc
0.4500
+45.16%
MBX MBX Biosciences, Inc.
9.25
+2.91%
VINC Vincerx Pharma, Inc. Common Stock
0.2750
+7.34%
PRAX Praxis Precision Medicines, Inc.
35.25
-3.68%
EDSA Edesa Biotech, Inc.
2.3570
-0.13%
KURA Kura Oncology, Inc.
6.31
-1.02%